Renovus Capital-backed ToxStrategies to acquire Suttons Creek.

Renovus Capital-backed ToxStrategies, a multidisciplinary scientific consulting firm, agreed to acquire Suttons Creek, a company that offers comprehensive consulting and execution services. Financial terms were not disclosed. “We are excited to welcome the Suttons Creek engineers, scientists, and regulatory specialists to our growing team of consultants. These experts work to assist clients in the pharmaceutical and medical device industries with the safety assessment, regulatory approval, commercialization, and transport of new, life-changing therapies and treatments. The Suttons Creek team expands and complements our current capabilities to include drug and biologic delivery systems. Suttons Creek offers expert-managed services and consulting that align with ToxStrategies’ mission of delivering unparalleled technical excellence to address our clients’ needs, with a spirit of collaboration and passion for advancing science,” Dr. Laurie Couture Haws, ToxStrategies President.